Viracta Therapeutics Inc (VIRX) Technical Exchange News Jan. 28, 2024, 23:25 UTC 36 0 comments NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Viracta Therapeutics, Inc. - Common Stock. Comment Full text
Viemed Healthcare Inc (VMD) Technical Exchange News Jan. 28, 2024, 23:25 UTC 37 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N. Comment Full text
Viking Therapeutics Inc. (VKTX) Technical Exchange News Jan. 28, 2024, 23:25 UTC 35 0 comments NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N. Comment Full text
Viemed Healthcare Inc (VMD) Technical Exchange News Jan. 28, 2024, 23:25 UTC 38 0 comments NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Viemed Healthcare, Inc. - Common Shares. Comment Full text
Viracta Therapeutics Inc (VIRX) Technical Exchange News Jan. 28, 2024, 23:25 UTC 32 0 comments NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N. Comment Full text
Viemed Healthcare Inc (VMD) Technical Exchange News Jan. 28, 2024, 23:25 UTC 38 0 comments NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N. Comment Full text
Viking Therapeutics Inc. (VKTX) Technical Exchange News Jan. 28, 2024, 23:25 UTC 37 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N. Comment Full text
Vir Biotechnology (VIR) Technical Exchange News Jan. 28, 2024, 23:25 UTC 37 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N. Comment Full text
Vigil Neuroscience Inc. (VIGL) Technical Exchange News Jan. 28, 2024, 23:25 UTC 34 0 comments NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N. Comment Full text
Virios Therapeutics Inc. (VIRI) Technical Exchange News Jan. 28, 2024, 23:25 UTC 36 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: D. Comment Full text